Munshi Amit

Munshi Amit is listed in filings as Director at Inhibikase Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 24, 2026, including purchase activity. Recent filings connect the profile to Inhibikase Therapeutics, Inc. (IKT), Arcutis Biotherapeutics, Inc. - Common stock (ARQT), and Galecto, Inc. (GLTO). The current snapshot covers public activity from Jun 21, 2024 to Feb 24, 2026. Reported amounts are shown as $514.2K to $210.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.